Abstract
Background
Few longitudinal studies available characterize long COVID outcomes out to 24 months, especially in people with nonsevere acute coronavirus disease 2019 (COVID-19). This study sought to prospectively characterize incidence and duration of long COVID symptoms and their...
Abstract
Objectives: We aimed to identify trajectories of the evolution of post-COVID-19 condition, up to 2 years after symptom onset.
Methods: The ComPaRe long COVID e-cohort is a prospective cohort of patients with symptoms lasting at least 2 months after SARS-CoV2 infection. We used...
Full title:
Assessment of Adult Patients with Long COVID Manifestations Suspected as Cardiovascular: A Single-Center Experience
Abstract
Background: Persistent symptoms affect a subset of coronavirus disease 2019 (COVID-19) survivors. Some of these may be cardiovascular (CV)-related...
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term debilitating multisystem condition with poor prognosis. Studies that examined predictors of ME/CFS outcomes yielded contradictory results.
We aimed to explore epidemiological and clinical prognostic factors of...
Full title:
The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization
Abstract
Post-COVID condition is prevalent in 10–35% of cases in outpatient settings, however a stratification of the duration and...
I'm interested to know how your ME has progressed in severity levels over all the years you have been sick.
For easier reading can you write first the amount of years sick with ME, how long each stage and severity level. Thanks.
For me:
26 years sick.
Progression:
Mild with severe cognitive...
Objective: To investigate the influence of comorbidities on the prognosis of pediatric postural tachycardia syndrome (POTS).
Methods: In this retrospective cohort study, 275 children with POTS admitted to the Department of Pediatrics at Peking University First Hospital were recruited from 2016...
R. Cairns, M. Hotopf, A systematic review describing the prognosis of chronic fatigue syndrome, Occupational Medicine, Volume 55, Issue 1, January 2005, Pages 20–31, https://doi.org/10.1093/occmed/kqi013
Content only available as PDF...
Now published, see https://www.s4me.info/threads/predictors-of-new-onsets-of-irritable-bowel-syndrome-chronic-fatigue-syndrome-and-fibromyalgia-the-lifelines-study-2019-monden-et-al.10637/#post-267644 for link to paper
Preprints with The Lancet...
Prognosis for childhood CFS is excellent
For other conference abstracts see this thread: https://www.s4me.info/threads/me-cfs-contributions-at-royal-college-of-paediatrics-and-child-health-conference-may-2019.9555/
Source: Archives of Disease in Childhood
Volume 104, Suppl 2
Date: May 2019
URL: https://adc.bmj.com/content/104/Suppl_2
Royal College of Paediatrics and Child Health
---------------------------------------------
Abstracts of the RCPCH Conference and exhibition 13–15 May 2019, ICC...
This post and the following ones have been moved from this thread.
I was just looking at this new paper from the author:
Measurements of Recovery and Predictors of Outcome in an Untreated Chronic Fatigue Syndrome Sample...
Hi all,
I'm trying to gather evidence for permanency of ME/CFS.
The health minister says that the NDIA are using the Australia 2002 guidelines. They're are pretty old and 5 years is a long time to wait with little support. I'm using evidence in the guidelines provided by the NHMRC to try...
"Dr. Rosamund Vallings Talks
The Irish ME/CFS Association is pleased to announce that it has arranged for Dr Ros Vallings, a leading international ME expert from New Zealand, to give 5 ME/Chronic Fatigue Syndrome talks in Ireland this May. The talks will include questions-and-answers sessions."...
I’m looking for some information around permanency, which is relevant when applying for disability supports. I’ve heard 5 years used as a figure (ie: if you’ve been ill for 5 years, the chances of recovery drop off significantly). Is there any data to back that up? How would permanency be...
Might increased serum NfL also be a potential biomarker for ME/CFS since it is for Alzheimer’s and other neurological disorders?
https://www.nature.com/articles/s41591-018-0304-3
https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00613/full
Highlighted in this post by @Roy S ,https://s4me.info/threads/me-cfs-and-the-biopsychosocial-model-a-review-of-patient-harm-and-distress-in-the-medical-encounter-geraghty-et-al-2018.4707/page-5#post-123442
Keith Geraghty says...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.